Loading insider details...
Beta
Latest Form 4 (May 15, 2026): Exercise/Conversion of 15,757 CERT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | Certara, Inc. (CERT) | Exercise/Conversion | 15,757 | n/a |
| Dec 2, 2025 | Theravance Biopharma, Inc. (TBPH) | Sale | 14,000 | $280.0K |
| Nov 14, 2025 | Theravance Biopharma, Inc. (TBPH) | Sale | 29,500 | $545.8K |
| May 22, 2025 | Certara, Inc. (CERT) | Exercise/Conversion | 11,928 | n/a |
| May 21, 2025 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 10,649 | n/a |
| May 23, 2024 | Certara, Inc. (CERT) | Exercise/Conversion | 8,663 | n/a |
| May 10, 2024 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 10,537 | n/a |
| Aug 23, 2023 | Certara, Inc. (CERT) | Purchase | 193 | $3.1K |
| May 25, 2023 | Certara, Inc. (CERT) | Exercise/Conversion | 9,360 | n/a |
| May 4, 2023 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 9,132 | n/a |